BeStock  
Stocks › Biotechnology › TARS

Tarsus Pharmaceuticals TARS

US equityMarket cap rank #2295Biotechnology
$73.01 −$4.66 (-6.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $71.00 -2.75%
Open$77.09
Prev close$77.67
Day range$72.57 – $78.11
Volume706.8K
Market cap$3.60B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-5.1x
CheapRich

Near the top of its 5-year range · 90th percentile, 5-year average -18.4x

Price / book38.0x
CheapRich

Near the top of its 5-year range · 100th percentile, 5-year average 5.4x

#5228 of 5330 stocks by PB (1 = cheapest)

Price / sales5.8x
CheapRich

Near the bottom of its 5-year range · 10th percentile, 5-year average 19.4x

#4079 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-81x-52x-23x6xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$69.36
Price vs. fair value+5.3%Trading above the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 38.05 – 5.35 100% (pricier than usual) #5228 of 5330 (1 = cheapest)
PE -5.06 -48.79 -18.42 90% (pricier than usual) –
PS 5.80 4.47 19.44 10% (cheaper than usual) #4079 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on TARS.

Sign in to join the discussion.

Scroll to Top